EUVIMEDEUVIMED entdecken
Crossref

Punica granatum L. (Pomegranate): Pharmacognostic and Pharmacological Insights

Dipali Mukesh Nandave, Meena Shamrao Deogade, Tanuja Manoj Nesari

International Journal of Drug Delivery Technology · 13.04.2026 · 16 (8s)

DOI: 10.25258/ijddt.16.8s.96 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.04.2026. Verfasst von Dipali Mukesh Nandave und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Punica granatum L. (pomegranate) is a medicinally relevant species of family Punicaceae, which has found widespread uses in various types of traditional medicine practices over centuries all over the world. The review was intended to synthesize a wealth of pharmacognostic and pharmacological information on Punica granatum by conducting a systematic secondary research methodology that included the examination of peer-reviewed literature, ethnobotanical accounts and pharmacopoeial monographs. Pharmacognostic standardization These parameters were definitive macroscopic and microscopic parameters of authentication such as ash values of 4.2 to 6.8, extractive values of 18.3 to 24.7, and TLC fingerprinting of punica granatum, ellagic acid, and gallic acid at Rf characteristic values. Phytochemical studies have established remarkably high bioactive constituent profiles such as punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum punica granatum Methanolic peel extracts containing 185.4 mg GAE/gram of total phenolic content directly supported excellent antioxidant activity exhibited through DPPH IC 0 50 of 18.4 0g/mL, which is higher than the ascorbic acid standard. Pharmacological analyses showed the presence of a broad-spectrum antimicrobial activity with a 62.5 µg/mL MIC against methicillin-resistant Staphylococcus aureus, potent NF-kB mediated antiinflammatory effect and selective anticancer cytotoxicity through caspase-mediated apoptosis against MCF-7, HT29 and LNCaP cancer cell lines. Further pharmacological results supported the normalization of hepatoprotective enzymes, high alpha-glucosidase inhibitory effects over acarbose and favourable acetylcholinesterase enzyme inhibitory effect indicative of neuroprotection. All these extensive results substantiate Punica granatum as a scientifically proven, phytochemically rich and pharmacologically potential medicinal plant that is in need of rapid clinical research and drug development.

Zitieren

APA

Nandave, D. M., Deogade, M. S., & Nesari, T. M. (2026). Punica granatum L. (Pomegranate): Pharmacognostic and Pharmacological Insights. International Journal of Drug Delivery Technology, 16(8s). https://doi.org/10.25258/ijddt.16.8s.96

Vancouver

Nandave DM, Deogade MS, Nesari TM. Punica granatum L. (Pomegranate): Pharmacognostic and Pharmacological Insights. International Journal of Drug Delivery Technology. 2026;16(8s). doi:10.25258/ijddt.16.8s.96

BibTeX
@article{Nandave2026,
  author = {Nandave, Dipali Mukesh and Deogade, Meena Shamrao and Nesari, Tanuja Manoj},
  title = {Punica granatum L. (Pomegranate): Pharmacognostic and Pharmacological Insights},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {8s},
  doi = {10.25258/ijddt.16.8s.96}
}
Kostenlos starten →